Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This study is designed to assess the levels of drug exposure following treatment with tislelizumab administered as a subcutaneous (SC) injection compared to intravenous infusion (IV) as first-line therapy in adults with gastric or gastroesophageal junction (GEJ) that is locally advanced and cannot be surgically removed or has spread from the stomach to other areas of the body. Approximately 351 patients will be participating in this study. The study is composed of a screening period, a treatment
Sponsor: BeiGene
Check if you qualify for this gastric cancer clinical trial in Houston, TX
If you're searching for gastric cancer treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.